Trial Profile
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jul 2021
Price :
$35
*
At a glance
- Drugs Defibrotide (Primary)
- Indications Hepatic veno-occlusive disease
- Focus Expanded access; Registrational; Therapeutic Use
- Acronyms T-IND
- Sponsors Jazz Pharmaceuticals Inc
- 04 Dec 2018 Results of a Pooled Analysis of CUP and T-IND trials (n=534) assessing the survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following HSCT, presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
- 17 Jun 2018 Results (n=1000) presented at the 23rd Congress of the European Haematology Association
- 12 Dec 2017 Final results of adult subgroup outcomes data (n=1000) presented at the 59th Annual Meeting and Exposition of the American Society of Hematology